ClinicalTrials.gg
CompletedNCT04279262Updated Dec 16, 2024

Community First Responders' Role in the Current and Future Rural Health and Care Workforce

An observational study in Emergency Medical Services, sponsored by University of Lincoln. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-16.

Sponsored by University of Lincoln · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
83,995
Ages
18 Years and older
Sex
All
01

Study summary

Community First Responders (CFRs) are trained members of the public, lay people or off-duty healthcare staff who volunteer to provide first aid. CFRs help ambulance services to provide care for people having health emergencies, from falls to road accidents to heart attacks, at home or in public places. CFRs are particularly important in rural areas where it is more difficult to provide or access emergency care, and where they are an important part of the care workforce. CFRs are broadly perceived to be positive, however evidence is needed about how they contribute to rural health services, which patients/conditions they attend, what care they provide, how effective they are and at what cost, how they are perceived by patients and other health workers, and how they could be developed to improve care for rural communities.

The investigators aim to develop recommendations for rural CFRs, by exploring their contribution to rural care, evaluating their value for money, understanding experiences and views of patients, CFRs and other healthcare staff, and exploring the potential for CFRs to provide new services.

Read the detailed description

The project will involve the following steps:

  1. Analyse records from six ambulance services to see: how many people CFRs attended; the proportion of ambulance calls attended; age, sex and conditions of people attended; how quickly CFRs attended and what happened to the patient(s) when the ambulance arrived.
  2. Evaluate benefits and costs of CFRs attending rural emergencies.
  3. Interview patients/relatives, ambulance staff, GPs, funders, CFRs and CFR leads to obtain views on rural CFR current and potential future roles. Interviews will also explore with CFRs and CFR leads, challenges and solutions to recruiting, training, retaining rural CFRs and ensuring safe, high quality care.
  4. Combine this knowledge (gained in steps1-3 above) to develop recommendations for change; who will be involved and how services should change to solve the most pressing problems for the rural communities served.
  5. Present recommendations to a workshop of experts and public to agree priorities for future development.
02

Conditions studied

  • Emergency Medical Services

Keywords

  • Community first responder
  • Rural health
  • Ambulance service
03

In context

Lead sponsor

University of Lincoln is the lead sponsor of 25 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

For the interview studies the investigators will purposively sample patients, relatives, and ambulance staff identified from records of patients who have been attended by a CFR in a rural location in the previous six months. Where possible the investigators will interview patients, relatives, CFRs and ambulance staff attending the same event. GPs will be purposively sampled from rural areas of the ambulance services involved. The investigators will recruit a maximum variation sample of patients (according to age, sex, condition, and ethnicity), ambulance staff (sex, experience, ethnicity and role), CFR (sex, ethnicity, length of experience, skill level) and CFR scheme leads (independent charity and ambulance trust overseen schemes).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults capable of giving . The investigators will recruit a maximum variation sample of patients (according to age, sex, condition, and ethnicity), ambulance staff (sex, experience, ethnicity and role), CFR (sex, ethnicity, length of experience, skill level) and CFR scheme leads (independent charity and ambulance trust overseen schemes).

Exclusion criteria

Exclusion Criteria:

  • The investigators will exclude children and adults who are unable to give from this study.

London Ambulance Service NHS Trust is not included as it is mainly urban; East of England Ambulance Service and North East Ambulance Service are not included because of lack of electronic data.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
83,995 participants (actual)
Patient registry
No

Groups and cohorts

  • Anonymised records from 6 ambulance services

    The total available sample for analysis for this cohort is estimated to be at least 50,000 incidents across 6 ambulance trusts. The investigators will describe the epidemiology of CFR provision to rural health areas using an anonymised dataset.

    Other: attendance by community first responders for medical emergencies

  • Interviews with patients (and/or relatives)

    The investigators will interview about 15-20 patients (and/or relatives) who have been attended by CFRs.

    Other: attendance by community first responders for medical emergencies

  • Interviews with CFRs

    The investigators will interview about 15-20 CFRs/ CFR scheme leaders.

  • Interviews with Ambulance staff

    The investigators will interview about 15-20 ambulance staff who have experience of working with CFRs.

  • Interviews with GPs and commisioners

    The investigators will interview about 10-15 GPs and ambulance service commissioners.

Interventions

  • Otherattendance by community first responders for medical emergencies

    The investigators will purposively sample patients, relatives, and ambulance staff identified from records of patients who have been attended by a CFR in a rural location in the previous six months. Where possible the investigators will interview patients, relatives, CFRs and ambulance staff attending the same event. GPs will be purposively sampled from rural areas of the ambulance services involved. Investigators will recruit a maximum variation sample of patients (according to age, sex, condition, and ethnicity), ambulance staff (sex, experience, ethnicity and role), CFR (sex, ethnicity, length of experience, skill level) and CFR scheme leads (independent charity and ambulance trust overseen schemes).

06

What researchers measure

Primary outcomes

  1. Number of ambulance calls that CFRs attend in one year

    We will establish how many people CFRs attended and work out the proportion of ambulance calls attended.

    Time frame: we will evaluate all emergency attendances during one year

  2. The type of cases treated by CFRs

    characteristics of people (age, sex, condition) attended

    Time frame: we will evaluate all emergency attendances during one year

  3. How quickly cases are dealt with

    how quickly they attend

    Time frame: we will evaluate all emergency attendances during one year

  4. Treatments given and transfer to hospital

    we will evaluate the treatments provided and the number of cases transferred to hospital

    Time frame: we will evaluate all emergency attendances during one year

  5. Locations

    We will describe rurality and location (eg. at home or elsewhere) where CFRs give treatment.

    Time frame: we will evaluate all emergency attendances during one year

Secondary outcomes

  1. Perceptions of CFR schemes

    We will interview different stakeholders (patients, CFRs, GPs, ambulance staff, CFR leads)

    Time frame: participants will have been involved in a CFR attendance in the previous 6 months

07

Study locations

1 site
  • Community and Health Research Unit, University of Lincoln
    Lincoln, Lincolnshire LN5 7AY, United Kingdom
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2020 to primary completion in May 2022, 23 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2020
First posted
Feb 21, 2020
StartActual
Jun 1, 2020
Primary completionActual
May 1, 2022
CompletionActual
Dec 3, 2022
Last update
Dec 16, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04279262
Lead sponsor
University of Lincoln
Responsible party
Sponsor
First posted
Feb 21, 2020
Start date
Jun 1, 2020
Primary completion
May 1, 2022
Completion
Dec 3, 2022
Last update
Dec 16, 2024

Study contacts

Niro Siriwardena
principal investigator · University of Lincoln, UK

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion